Navigation Links
Sharps Compliance Corp. Announces Appointment of John R. Grow as President and Chief Operating Officer

HOUSTON, Oct. 31 /PRNewswire-FirstCall/ -- Sharps Compliance Corp. (OTC Bulletin Board: SCOM) ("Sharps" or the "Company"), a leading provider of cost-effective disposal solutions for small quantity generators of medical waste, today announced the appointment of John "Randy" Grow as the Company's President and Chief Operating Officer, effective October 27, 2008. Mr. Grow, who has been a member of the Company's Board of Directors since October of 2005, will retain his position on the Board. Dr. Burton Kunik will continue to hold the positions of Chairman of the Board and Chief Executive Officer.

Mr. Grow was one of the founding members and President of Accredo Health, Inc., a specialty provider of biopharmaceuticals and services. Under his leadership, Accredo grew to a $1.5 billion company after its initial public offering in 1999 until it was acquired by Medco Health Solutions. Prior to his career with Accredo Health, Mr. Grow was a Vice President with Caremark Homecare, a home infusion service provider, and American Hospital Supply, a manufacturer and distributor of surgical supplies.

Dr. Burton J. Kunik, Chairman and Chief Executive Officer of Sharps Compliance, commented, "We are facing a period of unprecedented growth in the demand for our products and services and an abundance of large sales opportunities across the nation. Not only will Randy's extensive industry experience and knowledge help us win new customer contracts, his success in guiding rapidly growing businesses will be invaluable to the successful growth and execution of our day-to-day operations."

Mr. Grow, President and Chief Operating Officer of Sharps Compliance, commented, "Burt's vision and guidance have been key components to our current industry leadership position and success to-date. I believe with the strengthened senior management team that we now have in place, we are poised for accelerated sales growth and increased profitability in the second half of fiscal 2009 and beyond."

About Sharps Compliance Corp.

Headquartered in Houston, Texas, Sharps Compliance is a leading provider of cost-effective disposal solutions for small quantity generators of medical waste and unused pharmaceuticals. The Company's flagship product, the Sharps Disposal by Mail System(R), is a cost-effective and easy-to-use solution to dispose of medical waste such as hypodermic needles, lancets and any other medical device or objects used to puncture or lacerate the skin (referred to as "sharps"). The Company also offers a number of products specifically designed for the home healthcare market and products for the safe disposal of unused pharmaceuticals, RxTakeAway(TM). Sharps Compliance focuses on targeted growth markets such as the pharmaceutical, retail, commercial, and hospitality markets, as well as serving a variety of additional markets. Sharps is a leading proponent and participant in the development of public awareness and solutions for the safe disposal of needles, syringes and other sharps in the community setting.

As a fully integrated manufacturer providing customer solutions and services, Sharps Compliance's solid business model, with strong margins and significant operating leverage, and early penetration into emerging markets, uniquely positions the company for strong future growth.

More information on Sharps Compliance can be found on its website at:

For more information contact: - OR -

David P. Tusa Tammy Poblete

Executive Vice President, Chief Financial Kei Advisors LLC

Officer & Business Development Investor Relations

Phone: (713) 660-3514 Phone: (716) 843-3853

SOURCE Sharps Compliance Corp.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Sharps Compliance Corp. Announces Purchase of Medical Waste Disposal Facility and Addition of Autoclave Technology
3. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
4. FDA and Conformia Deliver Joint Presentation to Annual Regulatory and Compliance Symposium at Harvard
5. Sigma-Aldrich and Lab Manager Magazine Present Webinar On Laboratory Environmental, Health and Safety Compliance Strategies
6. Pressure BioSciences, Inc. Announces CE Mark Approval and Compliance with the IEC 61010-1 Standard for a Second PCT-based Instrument, the Barocycler NEP2320
7. New White Paper Details Strategies for Biotechnology Companies to Improve EH&S Compliance
8. Vermillion, Inc. Announces Receipt Of Notice Of Compliance From Nasdaq
9. NASDAQ Panel Grants Merge Technologies Additional Time to Regain Compliance
10. Genta Receives Notice of Non-Compliance with Listing Requirement for NASDAQ Global Market
11. Siemens Building Technologies Helping Companies Participate in EPA Labs21 Movement With Comprehensive Compliance Solution Strategy
Post Your Comments:
(Date:11/30/2015)... 2015 Partnership includes an MPP ... for the u niversity , s ... treatment s cale - up through ... Africa , where licensees based anywhere in the world will have ... --> Africa , where licensees based anywhere in the world ...
(Date:11/30/2015)... /PRNewswire/ - Zenith Epigenetics Corp. ("Zenith" or the "Company") today ... to its Board of Directors to replace Dr. ... wealth of experience as co-founder of Resverlogix, with expertise in ... --> --> Dr. Wong remarked, "I am ... Zenith,s long standing expertise in epigenetics and the advanced stage ...
(Date:11/30/2015)... Nov. 30, 2015  Champions Oncology, Inc. (CSBR), engaged ... to personalize the development and use of oncology drugs, ... Officer, will be presenting at the LD MICRO Investor ... Standard Time (PST).  The conference, held at the Luxe ... CA , will feature 200 small/micro-cap companies and ...
(Date:11/30/2015)... -- HUYA Bioscience International, the leader in accelerating global development ... announced it has signed a Memorandum of Understanding with ... between KDDF and HUYA with the ultimate goal of ... the global market. China,s ... preclinical and clinical stage compounds. The company advances the ...
Breaking Biology Technology:
(Date:11/10/2015)... Nov. 10, 2015 About ... that helps to identify and verify the identity ... considered as the secure and accurate method of ... a particular individual because each individual,s signature is ... especially when dynamic signature of an individual is ...
(Date:11/9/2015)... Nov. 9, 2015  Synaptics Inc. (NASDAQ: SYNA ... announced broader entry into the automotive market with a ... the pace of consumer electronics human interface innovation. Synaptics, ... ideal for the automotive industry and will be implemented ... Europe , Japan , ...
(Date:11/2/2015)... PARK, Calif. , Nov. 2, 2015  SRI ... $9 million to provide preclinical development services to the ... the contract, SRI will provide scientific expertise, modern testing ... wide variety of preclinical pharmacology and toxicology studies to ... --> The PREVENT Cancer Drug Development ...
Breaking Biology News(10 mins):